Literature DB >> 19601594

New arylthioindoles and related bioisosteres at the sulfur bridging group. 4. Synthesis, tubulin polymerization, cell growth inhibition, and molecular modeling studies.

Giuseppe La Regina1, Taradas Sarkar, Ruoli Bai, Michael C Edler, Roberto Saletti, Antonio Coluccia, Francesco Piscitelli, Lara Minelli, Valerio Gatti, Carmela Mazzoccoli, Vanessa Palermo, Cristina Mazzoni, Claudio Falcone, Anna Ivana Scovassi, Vincenzo Giansanti, Pietro Campiglia, Amalia Porta, Bruno Maresca, Ernest Hamel, Andrea Brancale, Ettore Novellino, Romano Silvestri.   

Abstract

New arylthioindoles along with the corresponding ketone and methylene compounds were potent tubulin assembly inhibitors. As growth inhibitors of MCF-7 cells, sulfur derivatives were superior or sometimes equivalent to the ketones, while methylene derivatives were substantially less effective. Esters 24, 27-29, 36, 39, and 41 showed approximately 50% of inhibition on human HeLa and HCT116/chr3 cells at 0.5 microM, and these compounds inhibited the growth of HEK, M14, and U937 cells with IC(50)'s in the 78-220 nM range. While murine macrophage J744.1 cell growth was significantly less affected (20% at higher concentrations), four other nontransformed cell lines remained sensitive to these esters. The effect of drug treatment on cell morphology was examined by time-lapse microscopy. In a protocol set up to evaluate toxicity on the Saccharomyces cerevisiae BY4741 wild type strain, compounds 24 and 54 strongly reduced cell growth, and 29, 36, and 39 also showed significant inhibition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19601594      PMCID: PMC2797757          DOI: 10.1021/jm900016t

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  23 in total

Review 1.  Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin.

Authors:  Ernest Hamel
Journal:  Cell Biochem Biophys       Date:  2003       Impact factor: 2.194

2.  Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain.

Authors:  Raimond B G Ravelli; Benoît Gigant; Patrick A Curmi; Isabelle Jourdain; Sylvie Lachkar; André Sobel; Marcel Knossow
Journal:  Nature       Date:  2004-03-11       Impact factor: 49.962

Review 3.  Medicinal chemistry of combretastatin A4: present and future directions.

Authors:  Gian Cesare Tron; Tracey Pirali; Giovanni Sorba; Francesca Pagliai; Sara Busacca; Armando A Genazzani
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

4.  Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites.

Authors:  Rubén M Buey; Enrique Calvo; Isabel Barasoain; Oriol Pineda; Michael C Edler; Ruth Matesanz; Gemma Cerezo; Christopher D Vanderwal; Billy W Day; Erik J Sorensen; Juan Antonio López; José Manuel Andreu; Ernest Hamel; J Fernando Díaz
Journal:  Nat Chem Biol       Date:  2007-01-07       Impact factor: 15.040

5.  Palladium-catalyzed, modular synthesis of highly functionalized indoles and tryptophans by direct annulation of substituted o-haloanilines and aldehydes.

Authors:  Yanxing Jia; Jieping Zhu
Journal:  J Org Chem       Date:  2006-09-29       Impact factor: 4.354

6.  New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies.

Authors:  Gabriella De Martino; Michael C Edler; Giuseppe La Regina; Antonio Coluccia; Maria Chiara Barbera; Denise Barrow; Robert I Nicholson; Gabriela Chiosis; Andrea Brancale; Ernest Hamel; Marino Artico; Romano Silvestri
Journal:  J Med Chem       Date:  2006-02-09       Impact factor: 7.446

7.  Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure-activity relationships and molecular modeling studies.

Authors:  Giuseppe La Regina; Michael C Edler; Andrea Brancale; Sahar Kandil; Antonio Coluccia; Francesco Piscitelli; Ernest Hamel; Gabriella De Martino; Ruth Matesanz; José Fernando Díaz; Anna Ivana Scovassi; Ennio Prosperi; Antonio Lavecchia; Ettore Novellino; Marino Artico; Romano Silvestri
Journal:  J Med Chem       Date:  2007-05-12       Impact factor: 7.446

Review 8.  The clinical development of new mitotic inhibitors that stabilize the microtubule.

Authors:  Sridhar Mani; Manuel Macapinlac; Sanjay Goel; Dominik Verdier-Pinard; Tito Fojo; Mace Rothenberg; Dimitrios Colevas
Journal:  Anticancer Drugs       Date:  2004-07       Impact factor: 2.248

9.  Phosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson.

Authors:  Piotr Zabrocki; Ilse Bastiaens; Charlotte Delay; Tine Bammens; Ruben Ghillebert; Klaartje Pellens; Claudio De Virgilio; Fred Van Leuven; Joris Winderickx
Journal:  Biochim Biophys Acta       Date:  2008-06-19

10.  4- and 5-aroylindoles as novel classes of potent antitubulin agents.

Authors:  Jing-Ping Liou; Chang-Ying Wu; Hsing-Pang Hsieh; Chi-Yen Chang; Chi-Ming Chen; Ching-Chuan Kuo; Jang-Yang Chang
Journal:  J Med Chem       Date:  2007-08-08       Impact factor: 7.446

View more
  19 in total

1.  Design and synthesis of 2-heterocyclyl-3-arylthio-1H-indoles as potent tubulin polymerization and cell growth inhibitors with improved metabolic stability.

Authors:  Giuseppe La Regina; Ruoli Bai; Willeke Rensen; Antonio Coluccia; Francesco Piscitelli; Valerio Gatti; Alessio Bolognesi; Antonio Lavecchia; Ilaria Granata; Amalia Porta; Bruno Maresca; Alessandra Soriani; Maria Luisa Iannitto; Marisa Mariani; Angela Santoni; Andrea Brancale; Cristiano Ferlini; Giulio Dondio; Mario Varasi; Ciro Mercurio; Ernest Hamel; Patrizia Lavia; Ettore Novellino; Romano Silvestri
Journal:  J Med Chem       Date:  2011-11-21       Impact factor: 7.446

2.  Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3'-hydroxy-4'-methoxyphenyl)-3-(3″,4″,5″-trimethoxybenzoyl)-6-methoxyindole (OXi8006).

Authors:  Matthew T Macdonough; Tracy E Strecker; Ernest Hamel; John J Hall; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  Bioorg Med Chem       Date:  2013-07-23       Impact factor: 3.641

3.  Antiproliferative 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides, a new tubulin inhibitor chemotype.

Authors:  Mikhail Krasavin; Andrey V Sosnov; Ruben Karapetian; Igor Konstantinov; Olga Soldatkina; Elena Godovykh; Fedor Zubkov; Ruoli Bai; Ernest Hamel; Andrei A Gakh
Journal:  Bioorg Med Chem Lett       Date:  2014-08-08       Impact factor: 2.823

Review 4.  An overview of tubulin inhibitors that interact with the colchicine binding site.

Authors:  Yan Lu; Jianjun Chen; Min Xiao; Wei Li; Duane D Miller
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

5.  New pyrrole derivatives with potent tubulin polymerization inhibiting activity as anticancer agents including hedgehog-dependent cancer.

Authors:  Giuseppe La Regina; Ruoli Bai; Antonio Coluccia; Valeria Famiglini; Sveva Pelliccia; Sara Passacantilli; Carmela Mazzoccoli; Vitalba Ruggieri; Lorenza Sisinni; Alessio Bolognesi; Whilelmina Maria Rensen; Andrea Miele; Marianna Nalli; Romina Alfonsi; Lucia Di Marcotullio; Alberto Gulino; Andrea Brancale; Ettore Novellino; Giulio Dondio; Stefania Vultaggio; Mario Varasi; Ciro Mercurio; Ernest Hamel; Patrizia Lavia; Romano Silvestri
Journal:  J Med Chem       Date:  2014-07-29       Impact factor: 7.446

6.  3-Aroyl-1,4-diarylpyrroles Inhibit Chronic Myeloid Leukemia Cell Growth through an Interaction with Tubulin.

Authors:  Giuseppe La Regina; Ruoli Bai; Antonio Coluccia; Valeria Famiglini; Sara Passacantilli; Valentina Naccarato; Giorgio Ortar; Carmela Mazzoccoli; Vitalba Ruggieri; Francesca Agriesti; Claudia Piccoli; Tiziana Tataranni; Marianna Nalli; Andrea Brancale; Stefania Vultaggio; Ciro Mercurio; Mario Varasi; Concetta Saponaro; Sara Sergio; Michele Maffia; Addolorata Maria Luce Coluccia; Ernest Hamel; Romano Silvestri
Journal:  ACS Med Chem Lett       Date:  2017-04-26       Impact factor: 4.345

7.  Synthesis and biological evaluation of 2-(alkoxycarbonyl)-3-anilinobenzo[b]thiophenes and thieno[2,3-b]pyridines as new potent anticancer agents.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Kimatrai Salvador; Delia Preti; Mojgan Aghazadeh Tabrizi; Marcella Bassetto; Andrea Brancale; Ernest Hamel; Ignazio Castagliuolo; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  J Med Chem       Date:  2013-03-18       Impact factor: 7.446

8.  Arylthioindoles: Promising compounds against cancer cell proliferation.

Authors:  Vincenzo Giansanti; Francesco Piscitelli; Tania Camboni; Ennio Prosperi; Giuseppe LA Regina; Michele Parks; Romano Silvestri; Anna Ivana Scovassi
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

9.  Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors.

Authors:  Giuseppe La Regina; Ruoli Bai; Whilelmina Maria Rensen; Erica Di Cesare; Antonio Coluccia; Francesco Piscitelli; Valeria Famiglini; Alessia Reggio; Marianna Nalli; Sveva Pelliccia; Eleonora Da Pozzo; Barbara Costa; Ilaria Granata; Amalia Porta; Bruno Maresca; Alessandra Soriani; Maria Luisa Iannitto; Angela Santoni; Junjie Li; Marlein Miranda Cona; Feng Chen; Yicheng Ni; Andrea Brancale; Giulio Dondio; Stefania Vultaggio; Mario Varasi; Ciro Mercurio; Claudia Martini; Ernest Hamel; Patrizia Lavia; Ettore Novellino; Romano Silvestri
Journal:  J Med Chem       Date:  2012-12-27       Impact factor: 7.446

10.  Cytotoxic activities of substituted 3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones and studies on their mechanisms of action.

Authors:  Aldo Andreani; Massimiliano Granaiola; Alessandra Locatelli; Rita Morigi; Mirella Rambaldi; Lucilla Varoli; Francesco Vieceli Dalla Sega; Cecilia Prata; Tam L Nguyen; Ruoli Bai; Ernest Hamel
Journal:  Eur J Med Chem       Date:  2013-04-03       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.